The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents.
Sloan
Edward P
EP
D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D001802:Blood Substitutes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005062:European Union; D006454:Hemoglobins / Q000627:therapeutic use*; D006801:Humans; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000209:etiology; D014947:Wounds and Injuries / Q000150:complications
D001802:Blood Substitutes; D006454:Hemoglobins; C083478:diaspirin-cross-linked hemoglobin; D001241:Aspirin